What did STAT’s Sept. 18, 2026 biotech roundup highlight about Roche and Xenon Pharma?

STAT News’ Sept. 18, 2026 biotech roundup, based on the RSS summary, highlighted Roche expanding its Boston footprint with a new research center, a gene therapy approval for Sanfilippo syndrome, and mixed “good and bad” news for Xenon Pharma. The excerpt offers little detail on deal terms, product names, regulators, or trial specifics.